Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Intra-Cellular Therapies Inc shares valued at $4,375,659 were sold by Mates Sharon on Dec 04 ’24. At $85.80 per share, Mates Sharon sold 51,000 shares. The insider’s holdings dropped to 1,070,329 shares worth approximately $140.6 million following the completion of this transaction.
Also, Mates Sharon sold 51,697 shares, netting a total of over 4,346,842 in proceeds. Following the sale of shares at $84.08 each, the insider now holds 1,070,329 shares.
Before that, Mates Sharon had added 51,697 shares to its account. In a trade valued at $4,343,616, the Officer bought Intra-Cellular Therapies Inc shares for $84.02 each.
As published in a research note from Mizuho on February 24, 2025, Intra-Cellular Therapies Inc [ITCI] has been rated down from an Outperform to a Neutral and the price target has been revised to $132 from $140. Analysts at Canaccord Genuity downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late January. As of September 06, 2024, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for ITCI. Earlier on January 03, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for ITCI stock.
Analyzing ITCI Stock Performance
During the last five days, there has been a surge of approximately 0.08%. Over the course of the year, Intra-Cellular Therapies Inc shares have jumped approximately 57.28%. Shares of the company reached a 52-week high of $131.38 on 03/13/25 and a 52-week low of $80.82 on 01/07/25. A 50-day SMA is recorded $121.30, while a 200-day SMA reached $88.18.
Support And Resistance Levels for Intra-Cellular Therapies Inc (ITCI)
According to the 24-hour chart, there is a support level at 131.26, which, if violated, would cause prices to drop to 131.16. In the upper region, resistance lies at 131.42. The next price resistance is at 131.47. RSI (Relative Strength Index) is 85.33 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.04, which suggests the price will increase in the coming days. Percent R is at 0.45%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
